Literature DB >> 24418676

Membrane culture and reduced oxygen tension enhances cartilage matrix formation from equine cord blood mesenchymal stromal cells in vitro.

C Co1, M K Vickaryous2, T G Koch3.   

Abstract

OBJECTIVE: Ongoing research is aimed at increasing cartilage tissue yield and quality from multipotent mesenchymal stromal cells (MSC) for the purpose of treating cartilage damage in horses. Low oxygen culture has been shown to enhance chondrogenesis, and novel membrane culture has been proposed to increase tissue yield and homogeneity. The objective of this study was to evaluate and compare the effect of reduced oxygen and membrane culture during in vitro chondrogenesis of equine cord blood (CB) MSC.
METHODS: CB-MSC (n = 5 foals) were expanded at 21% oxygen prior to 3-week differentiation in membrane or pellet culture at 5% and 21% oxygen. Assessment included histological examination (H&E, toluidine Blue, immunohistochemistry (IHC) for collagen type I and II), protein quantification by hydroxyproline assay and dimethylmethylene assay, and mRNA analysis for collagen IA1, collagen IIA1, collagen XA1, HIF1α and Sox9.
RESULTS: Among treatment groups, 5% membrane culture produced neocartilage most closely resembling hyaline cartilage. Membrane culture resulted in increased wet mass, homogenous matrix morphology and an increase in total collagen content, while 5% oxygen culture resulted in higher GAG and type II collagen content. No significant differences were observed for mRNA analysis.
CONCLUSION: Membrane culture at 5% oxygen produces a comparatively larger amount of higher quality neocartilage. Matrix homogeneity is attributed to a uniform diffusion gradient and reduced surface tension. Membrane culture holds promise for scale-up for therapeutic purposes, for cellular preconditioning prior to cytotherapeutic applications, and for modeling system for gas-dependent chondrogenic differentiation studies. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D culture; Differentiation; Hypoxic culture; Stem cells; Tissue engineering

Mesh:

Substances:

Year:  2014        PMID: 24418676     DOI: 10.1016/j.joca.2013.12.021

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  11 in total

1.  Effects of hypoxia on proliferation of human cord blood-derived mesenchymal stem cells.

Authors:  Longying Peng; Xiaomei Shu; Changhui Lang; Xiaohua Yu
Journal:  Cytotechnology       Date:  2015-03-06       Impact factor: 2.058

2.  Canine Platelet Lysate Is Inferior to Fetal Bovine Serum for the Isolation and Propagation of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.

Authors:  Keith A Russell; Thomas W G Gibson; Andrew Chong; Carmon Co; Thomas G Koch
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 3.  Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment.

Authors:  Michał Lach; Tomasz Trzeciak; Magdalena Richter; Jarosław Pawlicz; Wiktoria M Suchorska
Journal:  J Tissue Eng       Date:  2014-09-30       Impact factor: 7.813

4.  Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineering.

Authors:  Tangni Gómez-Leduc; Magalie Hervieu; Florence Legendre; Mouloud Bouyoucef; Nicolas Gruchy; Laurent Poulain; Claire de Vienne; Michel Herlicoviez; Magali Demoor; Philippe Galéra
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

5.  Extracellular matrix components and culture regimen selectively regulate cartilage formation by self-assembling human mesenchymal stem cells in vitro and in vivo.

Authors:  Johnathan Ng; Yiyong Wei; Bin Zhou; Aonnicha Burapachaisri; Edward Guo; Gordana Vunjak-Novakovic
Journal:  Stem Cell Res Ther       Date:  2016-12-09       Impact factor: 6.832

6.  Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.

Authors:  Keith A Russell; Natalie H C Chow; David Dukoff; Thomas W G Gibson; Jonathan LaMarre; Dean H Betts; Thomas G Koch
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

7.  Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy.

Authors:  Mélanie Desancé; Romain Contentin; Lélia Bertoni; Tangni Gomez-Leduc; Thomas Branly; Sandrine Jacquet; Jean-Marc Betsch; Agnès Batho; Florence Legendre; Fabrice Audigié; Philippe Galéra; Magali Demoor
Journal:  Int J Mol Sci       Date:  2018-02-10       Impact factor: 5.923

8.  Aspiration, but not injection, decreases cultured equine mesenchymal stromal cell viability.

Authors:  Lynn B Williams; Keith A Russell; Judith B Koenig; Thomas G Koch
Journal:  BMC Vet Res       Date:  2016-03-07       Impact factor: 2.741

9.  Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media.

Authors:  Lynn B Williams; Carmon Co; Judith B Koenig; Crystal Tse; Emily Lindsay; Thomas G Koch
Journal:  Front Vet Sci       Date:  2016-07-22

10.  Hypoxia Is a Critical Parameter for Chondrogenic Differentiation of Human Umbilical Cord Blood Mesenchymal Stem Cells in Type I/III Collagen Sponges.

Authors:  Tangni Gómez-Leduc; Mélanie Desancé; Magalie Hervieu; Florence Legendre; David Ollitrault; Claire de Vienne; Michel Herlicoviez; Philippe Galéra; Magali Demoor
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.